Drug intelligence / Profile preview

UQP15

Development stage
Preclinical
Lead developer
BioGene Therapeutics
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intranasal
01

Overview

UQP15 is a preclinical-stage siRNA therapeutic developed by BioGene Therapeutics for the treatment of diabetes and obesity. It utilizes "Smart-siRNA" technology to target and silence the mRNA of Protein Tyrosine Phosphatase 1B (PTP1B), a negative regulator of insulin and leptin signaling. The drug is formulated in bioresponsive lipid nanoparticles (bLNPs) and delivered via an intranasal nose-to-brain spray using a Sol-Gel platform. This delivery method is intended to bypass the blood-brain barrier, allowing the siRNA to modulate metabolic pathways within the central nervous system.

02

Targets

PTPN1 (Protein tyrosine phosphatase 1B)

Beyond the preview

Go deeper on UQP15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UQP15.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call